Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
Bastu Odoka, Transfusion Scientist at Effia-Nkwanta Regional Hospital, shared a post on LinkedIn:
”Blood should NOT be left at the bedside to ‘warm’.
This is still a common practice in many clinical settings. The intention is good. The risk, however, is real.
Red blood cells are stored at 2–6°C to maintain safety and quality. Once a unit leaves controlled storage, the clock starts.
The 30-Minute Rule
If transfusion has not started within 30 minutes, the blood should be returned to the blood bank refrigerator. After this window, the unit may become unsafe for use due to temperature exposure and bacterial growth risk.
Many assume leaving blood at room temperature helps it warm. Evidence shows otherwise. Blood left out for 30 minutes typically only reaches about 8–10°C, which provides no clinical benefit.
In a routine transfusion, blood can safely be administered cold. The patient’s circulation warms rapidly.
When warming is actually required
Blood warming should only be used in specific situations, such as:
- Massive transfusion (large volumes in a short time)
- Rapid transfusion at high flow rates
- Neonates or patients at high risk of hypothermia
And importantly, warming must be done using approved medical blood warmers, never improvised methods.
- Safe practice protects patients
- Reduces wastage of scarce blood resources
- Supports better transfusion outcomes, especially in resource-limited settings
Safe blood use saves lives.
I’m interested to hear how different facilities enforce the 30-minute rule in practice.”
Stay updated with Hemostasis Today.
-
Jul 3, 2026, 13:31Javed Anees: TIA is a Medical Emergency – Not a Benign Warning
-
Jul 3, 2026, 12:46Heghine Khachatryan: 2026 AHA Guideline on the Management of CKM Syndrome
-
Jul 3, 2026, 12:32Shadi Tabibian: Beyond Bleeding – Women Living with von Willebrand Disease
-
Jul 3, 2026, 09:33Abdul Mannan: Not All Type 1 VWD Starts in the VWF Gene
-
Jul 3, 2026, 09:18Aryabhatta Sadhu: Sickle Cell Crisis – When Diagnostics Should Change Therapy
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia